Oncology PracticePersonalized cancer vaccine shows early promise across tumor typesApril 14, 2021Patient & Survivor CareMultiple MyelomaBreast CancerGenitourinary CancerLymphoma & Plasma Cell DisordersHead & Neck/Thyroid CancersLung Cancer
Hematology NewsEvidence favors lower-dose R-CHOP for fit, very elderly DLBCL patientsApril 14, 2021B Cell LymphomaDLBCLLymphoma & Plasma Cell Disorders
Oncology PracticeCombo provides ‘broad benefit’ across NHL subtypesApril 12, 2021Lymphoma & Plasma Cell DisordersIndolent Lymphoma
Oncology PracticeSteroid-refractory pneumonitis from ICIs: Experience at major centersApril 9, 2021Patient & Survivor CareLung CancerNonmelanoma Skin CancerMelanomaGastrointestinal CancerHead & Neck/Thyroid CancersLymphoma & Plasma Cell Disorders
Oncology PracticeCancer screening stopped by pandemic: Repercussions to come?April 8, 2021Patient & Survivor CareLung CancerBreast CancerGastrointestinal CancerGynecologic CancerCOVID-19 UpdatesMixed Topics
Hematology NewsSteroids can be stopped in some older multiple myeloma patientsApril 1, 2021Multiple MyelomaLymphoma & Plasma Cell Disorders
Hematology NewsFirst CAR T-cell therapy for multiple myeloma: AbecmaMarch 29, 2021Multiple MyelomaLymphoma & Plasma Cell Disorders
Hematology NewsPoor survival with COVID in patients who have had HSCTMarch 26, 2021CMLTransplantLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersALLDLBCLB Cell Lymphoma
Hematology NewsOmidubicel improves on umbilical cord blood transplantsMarch 22, 2021TransplantALLAMLCMLMyelodysplastic SyndromeB Cell LymphomaLeukemia, Myelodysplasia, Transplantation
Oncology PracticeFDA scrutinizes cancer therapies granted accelerated approvalMarch 18, 2021Patient & Survivor CareBreast CancerGastrointestinal CancerGenitourinary CancerLung CancerLymphoma & Plasma Cell DisordersMultiple Myeloma
Hematology NewsHigh-dose chemo no better than standard dose for B-cell lymphomaMarch 17, 2021B Cell LymphomaLymphoma & Plasma Cell Disorders
Oncology PracticeDon’t delay: Cancer patients need both doses of COVID vaccineMarch 15, 2021Patient & Survivor CareAggressive LymphomasB Cell LymphomaT Cell LymphomasMultiple MyelomaMantle Cell LymphomaIndolent Lymphoma
Hematology NewsNew inhibitor shows promise in previously failed B-cell malignanciesMarch 12, 2021CLLMantle Cell LymphomaLymphoma & Plasma Cell DisordersLeukemia, Myelodysplasia, TransplantationFollicular Lymphoma
Oncology PracticemCODE: Improving data sharing to enhance cancer careMarch 12, 2021Patient & Survivor CareBreast CancerCNS/Brain CancerGastrointestinal CancerGenitourinary CancerGynecologic CancerHead & Neck/Thyroid Cancers
Hematology News‘Phenomenal’ results with CAR T cells in R/R multiple myelomaMarch 4, 2021Multiple MyelomaLymphoma & Plasma Cell Disorders
